TL;DR: The AdvisorShares Pure US Cannabis ETF (MSOS) closed Friday at $4.34, gaining 1.64 percent on the session as the sector enters its most consequential earnings sprint of the year. With Green Thumb Industries reporting August 4 and Curaleaf Holdings following on August 5, institutional positioning ahead of Q2 results is beginning to register in Friday’s tape. The ETF remains more than 40 percent below its 52-week high, leaving meaningful recovery runway if operators deliver on profitability expectations.
Market Analysis
MSOS settled at $4.34 Friday, up from Thursday’s close of $4.27, with an intraday range of $4.18 to $4.39. Volume came in at approximately 2.28 million shares, well below the trailing average of 6.88 million — a pattern consistent with summer Friday sessions where institutional desks are lightly staffed and retail flow dominates. Despite subdued volume, the directional move was clean: buyers absorbed the morning dip to $4.18 and lifted the ETF to a close near the top of the day’s range.
The 52-week picture for MSOS frames the broader opportunity set. At $4.34, the ETF is trading at roughly 60 percent of its $7.25 one-year high and 57 percent above its $2.77 trough. Net assets of $1.05 billion confirm that institutional capital has not abandoned the thesis. The YTD gain of 9.53 percent is constructive, though it trails the broader market’s performance — a gap that Q2 earnings from the sector’s major operators could narrow if results demonstrate continued margin improvement.
Among the index constituents visible in Friday’s tape, the session delivered a split verdict. Curaleaf Holdings (CURLF) gained 1.72 percent to $9.46, extending a one-year return of approximately 158 percent while trading against analyst consensus targets of $15.00. The company’s August 5 earnings date represents the first major test of whether that rally reflects fundamental improvement or multiple expansion ahead of results. Green Thumb Industries (GTBIF), the only large-cap MSO currently posting consistent GAAP profitability, slipped 0.71 percent to $7.03 on modest volume — a reminder that even the sector’s financial standout trades at a fraction of its $15.67 average analyst target.
For GTBIF specifically, the setup into August 4 earnings is notable. The company delivered Q1 2026 revenue of $300.19 million with a trailing twelve-month profit margin of 10.14 percent — metrics that stand in sharp contrast to most cannabis peers. At a trailing P/E of 13.78 and an enterprise value-to-EBITDA of 3.43, the valuation is undemanding relative to cash generation. The stock’s 52-week high of $10.43 represents roughly 48 percent upside from current levels, and analyst price targets cluster between $10 and $20.
Regulatory and Market Context
The cannabis equity narrative for the second half of 2026 continues to run on two tracks: corporate execution and federal regulatory movement. On the execution side, the next 18 days represent the highest-density earnings window the sector has seen in 2026, with Green Thumb (August 4), Curaleaf (August 5), Tilray Brands (August 6), Canopy Growth (August 7), and Organigram Holdings (August 11) all reporting within a compressed window. The compressed calendar means that negative guidance from any one name can immediately reprice peers, while strong results could trigger a broad re-rating across the ETF.
On the regulatory front, the DEA’s rescheduling review of cannabis from Schedule I to Schedule III remains the overarching macro catalyst that has defined institutional interest in the sector since late 2024. The process has moved deliberately, with no material developments since early spring. Market participants have priced in the possibility of rescheduling without assigning it certainty — which is why names like CURLF continue to trade at steep discounts to consensus targets. A formal rescheduling announcement would represent a durable re-rating event for the entire sector.
State-level catalysts remain active as well. Florida’s recreational framework continues to mature following the 2024 ballot initiative, providing a direct revenue tailwind for operators with significant Sunshine State footprints. Ohio’s adult-use market, now approaching its one-year anniversary, is beginning to generate comparative-period data that should appear directly in Q2 results across several MSOs reporting this cycle.
Conclusion
The weekend of July 26 through 27 provides a brief window before Monday’s open brings the cannabis sector back into focus. With no scheduled macroeconomic data of direct relevance to cannabis, attention will turn to any state-level regulatory filings or DEA administrative docket activity that could surface before markets reopen. Earnings season will effectively begin for the cannabis sector on August 4 when Green Thumb reports after the close.
For investors tracking the space, MSOS’s Friday trading envelope of $4.18 to $4.39 represents a holding pattern that reflects both the opportunity and the uncertainty ahead. The ETF is neither breaking out nor breaking down. Whether that changes next week depends on whether any pre-announcement activity surfaces from management teams in the final days before their reporting dates. Follow real-time price movements and company updates on the cannabis stock tracker.